Advanced Accelerator Applications
Advanced Accelerator Applications is a company specializing in radioligand therapies (RLTs) for cancer care and radionuclide molecular imaging. They are leading the development of next-generation medicines aimed at improving quality of life and extending lives, with a focus on precision medicine approaches. The company was founded in 2002 and has a history rooted in innovative nuclear research.
Industries
Nr. of Employees
large (251-1000)
Advanced Accelerator Applications
Saint-genis-pouilly, Rhone-Alpes, France, Europe
Patents
Products
Fluorine-18 based PET imaging diagnostics
Diagnostic PET imaging agents that use fluorine-18 radioisotopes for molecular imaging applications.
Fluorine-18 based PET imaging diagnostics
Diagnostic PET imaging agents that use fluorine-18 radioisotopes for molecular imaging applications.
Services
Research and development and clinical delivery services for radioligand-based oncology therapeutics.
Design, manufacture and provision of radiopharmaceutical agents for PET imaging, including fluorine-18–based diagnostics.
Research and development and clinical delivery services for radioligand-based oncology therapeutics.
Design, manufacture and provision of radiopharmaceutical agents for PET imaging, including fluorine-18–based diagnostics.
Expertise Areas
- Radioligand therapy development
- Radiopharmaceutical manufacturing and supply
- Positron emission tomography (PET) diagnostics
- Radionuclide molecular imaging
Key Technologies
- Radioligand therapy
- Radiopharmaceuticals
- Positron emission tomography (PET)
- Fluorine-18 (F-18) radioisotopes